Horizon Therapeutics Plc

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
SAVACassava Sciences, Inc. -3.60%55.960.0%$456.84m
HZNPHorizon Therapeutics Plc -0.35%104.505.4%$199.74m
VRXValeant Pharmaceuticals International, Inc. -3.22%25.2714.1%$148.69m
CTLTCatalent, Inc. 2.17%132.402.0%$130.81m
ICLRICON plc -0.68%272.002.8%$116.32m
UTHRUnited Therapeutics Corp. -3.27%193.6413.9%$83.25m
BHCBausch Health Cos., Inc. -3.22%25.270.0%$75.17m
JAZZJazz Pharmaceuticals Plc -4.04%124.092.1%$63.68m
PRGOPerrigo Co. Plc -2.68%37.796.9%$58.52m
ARGXargenx SE -0.29%276.100.0%$52.50m
ENDPEndo International Plc -3.64%5.838.5%$52.32m
AXSMAxsome Therapeutics, Inc. -2.66%36.921.8%$26.01m
QLGNQualigen Therapeutics, Inc. -2.86%1.700.0%$23.79m
IRWDIronwood Pharmaceuticals, Inc. -3.63%11.169.5%$23.37m
ORMPOramed Pharmaceuticals, Inc. 6.82%20.210.5%$22.64m

Company Profile

Horizon Therapeutics Plc is a biopharmaceutical company, which is engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Rheumatology, and Inflammation segments. The Orphan and Rheumatology segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises of medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland.